One-third of Ebos revenue linked to Aust pharmacy policy, analyst warns

One-third of Ebos revenue linked to Aust pharmacy policy, analyst warns
About 300 common medicines will be dispensed less often through the Pharmaceutical Benefits Scheme. (Image: Ebos)
Rebecca Stevenson
Ebos chief executive John Cullity says the Australian government’s new dispensing rules will have a negligible impact on its margins because it has also increased funding to community pharmacies.In April this year, Australia’s government announced about 300 common medicines including those for heart failure, asthma, high cholesterol and diabetes could be dispensed less often through its Pharmaceutical Benefits Scheme (PBS), with patients able to collect 60 days of medicine rather than 30.The pharmacy sector had warned pharmacies wou...

More Markets

NZ sharemaket up 0.1% despite 'volatile' markets
Markets Market Close

NZ sharemaket up 0.1% despite 'volatile' markets

The S&P/NZX 50 Index closed at 12,338.57, up 18.38 points or 0.15%.

NZX-listed companies take stock in wake of US tariff moves
Economy

NZX-listed companies take stock in wake of US tariff moves

Wine makers, manufacturers and others mull what trade wars will bring.

Analysts struggle to find upside from Trump tariffs
Economy

Analysts struggle to find upside from Trump tariffs

‘They've forgotten the lessons of the Great Depression,’ one analyst said.